Termination of Study Sample Clauses

Termination of Study. After completion of the Study, Prospect shall deliver to Broker all Information including but not limited to all Notes, documents, and papers (including diskettes or other media for electronic storage of information) as they relate to any Information that is in the possession or under the control of Prospect, without making copies or summaries of any such Information, provided that in lieu of so delivering Notes prepared by Prospect, Prospect may destroy such Notes and provide Broker with a written certificate by an authorized representative of Prospect as to the fact of such destruction. Notwithstanding the foregoing, if the parties enter into a binding purchase agreement, Prospect may retain such Information. However, the retention of such Information shall be subject to the terms of the purchase agreement.
AutoNDA by SimpleDocs
Termination of Study at the Institution Upon Notice. Sponsor reserves the right to terminate the Study for any reason upon thirty (30) days written notice to Institution and Investigator. (2) Immediate Termination of Study at the Institution by Sponsor. Sponsor further reserves the right to terminate the Study immediately upon written notification to Institution and Investigator for causes that include material unauthorized deviations from the Protocol; circumstances that in Sponsor’s opinion pose risks to the health or well being of Study Subjects; or regulatory agency actions relating to the Study or the Sponsor Investigational Product or Comparator Product. (3) Immediate Termination of Study by Institution and/or Investigator. Institution and/or Investigator reserves the right to terminate the Study at the Institution immediately upon written notification to Sponsor if requested to do so by the responsible IEC or if such termination is required to protect the health of Study Subjects or if Institution decides that no suitable replacement for the Principal Investigator is available. a dokumenty ze Studie, a po přijetí všech plateb splatných kterékoli smluvní straně. b. Předčasné ukončení Studie ve Zdravotnickém zařízení. Pokud dojde k předčasnému ukončení Studie podle níže uvedených ustanovení, skončí platnost Smlouvy poté, co Zadavatel obdrží všechny relevantní údaje vyžadované podle Protokolu a dokumenty ze Studie, a po přijetí všech plateb splatných kterékoli smluvní straně. (1) Ukončení Studie ve Zdravotnickém zařízení na základě oznámení. Zadavatel si vyhrazuje právo s okamžitou platností ukončit Studii z jakéhokoli důvodu písemným oznámením zaslaným Zdravotnickému zařízení a Zkoušejícímu třicet (30) dnů předem. (2) Okamžité ukončení Studie ve Zdravotnickém zařízení Zadavatelem. Zadavatel si také vyhrazuje právo s okamžitou platností ukončit Studii písemným oznámením zaslaným Zdravotnickému zařízení a Zkoušejícímu z takových důvodů, jako jsou například závažné neoprávněné odchylky od Protokolu; okolnosti, které podle Zadavatelova názoru ohrožují zdraví nebo celkovou situaci Subjektů studie; nebo postupy regulatorních úřadů týkající se Studie nebo Zadavatelova Hodnoceného léčiva či Komparačního produktu. (3) Ukončení Studie Zdravotnickým zařízením a/nebo Zkoušejícím s okamžitou platností. Zdravotnické zařízení a/nebo Zkoušející si vyhrazují právo s okamžitou platností ukončit Studii ve Zdravotnickém zařízení písemným oznámením zaslaným Zadavateli, pokud o to bude žádat o...
Termination of Study. The Sponsor reserves the right to discontinue this study for administrative reasons at any time. The Investigator reserves the right to discontinue the study for safety reasons at any time in collaboration with the Sponsor.
Termination of Study. Treatment with the investigational drug may be ended if your small cell lung cancer recurs, if the doctors treating you see side effects that they consider dangerous, if you refuse to have the treatments as recommended by your doctor or if you refuse to have the tests needed to determine whether the treatment is safe and effective, or if you become pregnant. This research study has been reviewed by INSTITUTION'S Institutional Review Board. This Board is legally responsable for making sure that research with patients is appropriate and that the patient's rights and welfare are protected. The physician in charge of this research study is ______________, telephone number _____________ If you need more information about this study before you decide to join, or at any other time, you may wish to contact him. In the event that you do decide to participate, he should also be called if there are side effects from the treatment. A non-physician whom you may call for information about the consent process, research patient's rights, or research-related injury is _______________, telephone number _________ 71/102 89 [LOGO] The SILVX xxxdy -------------------------------------------------------------------------------- PATIENT INFORMED CONSENT FOR CLINICAL RESEARCH Title: SURVIVAL IN AN INTERNATIONAL PHASE III PROSPECTIVE RANDOMIZED LD SMALL CELL LUNG CANCER VACCINATION STUDY WITH ADJUVANT BEC2 AND BCG Purpose: To determine whether immunization with BEC2 in combination with BCG following chemotherapy in patients with limited disease small-cell lung cancer results in longer survival than chemotherapy alone. The study will also study the "progression free survival" in the two separate treatment groups, toxicities associated with the study agents BEC2 and BCG, and the effect of these agents on the patients quality of life.
Termination of Study. [***] the [***] the [***] with [***] to the [***]. In [***] the [***] will [***] is [***] to the [***] of the [***].
Termination of Study. Any PCD Program or particular Study under a PCD Program may be terminated by Isis, without cause, upon 30 days written notice.

Related to Termination of Study

  • Termination of 401(k) Plan The Company agrees to terminate its 401(k) plan immediately prior to the Closing, unless Parent, in its sole and absolute discretion, agrees to sponsor and maintain such plan by providing the Company with notice of such election at least five days before the Effective Time.

  • Termination of Review If a Review is in process and the Notes will be paid in full on the next Payment Date, the Servicer will notify the Asset Representations Reviewer and the Indenture Trustee no less than ten days before that Payment Date. On receipt of notice, the Asset Representations Reviewer will terminate the Review immediately and will not be obligated to deliver a Review Report.

  • Termination of Agreement If this Agreement is terminated by the Representatives in accordance with the provisions of Section 5 or Section 9(a)(i) hereof, the Company shall reimburse the Underwriters for all of their out-of-pocket expenses, including the reasonable fees and disbursements of counsel for the Underwriters.

  • Termination of Consulting Period Notwithstanding any other provision hereof, the Consulting Period and Consultant’s services as a consultant hereunder shall terminate, and, except as otherwise specifically provided herein, this Agreement shall terminate:

  • Termination of Company Upon the completion of the liquidation of the Company and the distribution of all Company assets, the Company's affairs shall terminate and the Liquidator shall cause to be executed and filed an appropriate certificate, if required, to such effect in the proper governmental office or offices, as well as any and all other documents required to effectuate the termination of the Company.

  • Termination of Benefits Except as provided in Section 2 above or as may be required by law, Executive’s participation in all employee benefit (pension and welfare) and compensation plans of the Company shall cease as of the Termination Date. Nothing contained herein shall limit or otherwise impair Executive’s right to receive pension or similar benefit payments that are vested as of the Termination Date under any applicable tax-qualified pension or other plans, pursuant to the terms of the applicable plan.

  • Termination of Status as an Employee If the Optionee ceases to serve as an Employee for any reason other than death or for Cause (as defined in the Plan) and thereby terminates his status as an Employee, the Optionee shall have the right to exercise this Option at any time within ninety (90) days following the date of such termination, to the extent that the Optionee was entitled to exercise the Option at the date of such termination, but in no event after the expiration of the term of the Option set forth in Section 2 hereof. If the Optionee ceases to serve as an Employee due to death, this Option may be exercised at any time within one (1) year following the date of death by the Optionee's executor or administrator or the person or persons who shall have acquired the Option by bequest or inheritance but only to the extent the Optionee was entitled to exercise this option at the date of death. To the extent that the Optionee was not entitled to exercise the Option at the date of termination or death, or to the extent the Option is not exercised within the time specified herein, this Option shall terminate. Notwithstanding the foregoing, this Option shall not be exercisable after the expiration of the term set forth in Section 2 hereof. If the Optionee ceases to serve as an Employee due to termination of his employment by the Company for cause (as defined in the Plan), this Option shall cease to be exercisable ten (10) days following the date the notice of such termination is delivered to the Optionee.

  • Effect of Termination of Service Except as otherwise provided in accordance with Section 4(b) above, if you cease to be a Service Provider, you will forfeit all unvested Units.

  • Confirmation of Status The parties confirm that the Asset Representations Reviewer is not responsible for (a) reviewing the Receivables for compliance with the representations and warranties under the Transaction Documents, except as described in this Agreement, or (b) determining whether noncompliance with the representations or warranties constitutes a breach of the Transaction Documents.

  • Forfeiture upon Termination of Status as a Service Provider Notwithstanding any contrary provision of this Award Agreement, the balance of the Restricted Stock Units that have not vested as of the time of Participant’s termination as a Service Provider for any or no reason and Participant’s right to acquire any Shares hereunder will immediately terminate.

Time is Money Join Law Insider Premium to draft better contracts faster.